Literature DB >> 1572989

Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors.

E K Subbarao1, Y Kawaoka, K Ryan-Poirier, M L Clements, B R Murphy.   

Abstract

The A/Los Angeles/2/87 (H3N2) (A/LA/2/87) virus is sensitive to inhibitors of hemagglutination present in certain human sera. It was found that the effect of these inhibitors could be removed by treating sera with high-concentration receptor-destroying enzyme or trypsin-periodate or by using inhibitor-resistant viruses in the hemagglutination inhibition (HAI) test. Inhibitor-resistant viruses were not effective for detecting rises in antibody titers in the sera of volunteers infected with the A/LA/2/87 wild-type virus, while rises in antibody titer were readily detected in sera treated with trypsin-periodate and tested against A/LA/2/87 wild-type virus in an HAI test. It is therefore suggested that chemical or enzymatic methods be used to inactivate serum inhibitors and that standard virus be used in the HAI test for the currently circulating H3N2 viruses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572989      PMCID: PMC265200          DOI: 10.1128/jcm.30.4.996-999.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Non-specific inhibitors of influenza viruses in normal sera.

Authors:  R ANANTHANARAYAN; C K PANIKER
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

Review 2.  Serum inhibitors of myxoviruses.

Authors:  O Krizanová; V Rathová
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

3.  Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites.

Authors:  G W Both; M J Sleigh; N J Cox; A P Kendal
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

4.  Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.

Authors:  K L van Wyke Coelingh; C C Winter; E L Tierney; S L Hall; W T London; H W Kim; R M Chanock; B R Murphy
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins.

Authors:  E M Anders; C A Hartley; D C Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Distinct glycoprotein inhibitors of influenza A virus in different animal sera.

Authors:  K A Ryan-Poirier; Y Kawaoka
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

8.  Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay.

Authors:  M H Snyder; S Banks; B R Murphy
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

9.  Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera.

Authors:  M L Wang; J J Skehel; D C Wiley
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

Authors:  G N Rogers; J C Paulson; R S Daniels; J J Skehel; I A Wilson; D C Wiley
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

View more
  14 in total

1.  Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.

Authors:  Gillian M Air; Jingqi Feng; Tao Chen; Michelle L Joachims; Judith A James; Linda F Thompson
Journal:  J Clin Immunol       Date:  2011-07-06       Impact factor: 8.317

2.  Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.

Authors:  Kwok-Hung Chan; Kelvin K W To; Ivan F N Hung; Anna J X Zhang; Jasper F W Chan; Vincent C C Cheng; Herman Tse; Xiao-Yan Che; Honglin Chen; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

3.  Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.

Authors:  C A Benne; F P Kroon; M Harmsen; L Tavares; C A Kraaijeveld; J C De Jong
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

4.  Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009.

Authors:  Brendan Klick; Hiroshi Nishiura; Sophia Ng; Vicky J Fang; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

5.  Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.

Authors:  Kim B Westgeest; Theo M Bestebroer; Monique I J Spronken; Jin Gao; Laura Couzens; Albert D M E Osterhaus; Maryna Eichelberger; Ron A M Fouchier; Miranda de Graaf
Journal:  J Virol Methods       Date:  2015-02-21       Impact factor: 2.014

6.  Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.

Authors:  Lisa Jolly; Anastasios Stavrou; Gilles Vanderstoken; Victoria A Meliopoulos; Anthony Habgood; Amanda L Tatler; Joanne Porte; Alan Knox; Paul Weinreb; Shelia Violette; Tracy Hussell; Martin Kolb; Martin R Stampfli; Stacey Schultz-Cherry; Gisli Jenkins
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

Review 7.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

8.  Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays.

Authors:  Kevin T Cwach; Heather R Sandbulte; Joshua M Klonoski; Victor C Huber
Journal:  Influenza Other Respir Viruses       Date:  2011-08-29       Impact factor: 4.380

9.  MicroRNA regulation of human protease genes essential for influenza virus replication.

Authors:  Victoria A Meliopoulos; Lauren E Andersen; Paula Brooks; Xiuzhen Yan; Abhijeet Bakre; J Keegan Coleman; S Mark Tompkins; Ralph A Tripp
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

10.  Serosurveillance for pandemic influenza A (H1N1) 2009 virus infection in domestic elephants, Thailand.

Authors:  Weena Paungpin; Witthawat Wiriyarat; Kridsada Chaichoun; Ekasit Tiyanun; Nareerat Sangkachai; Don Changsom; Kanaporn Poltep; Parntep Ratanakorn; Pilaipan Puthavathana
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.